PLASMODIUM FALCIPARUM MALARIA

Assessing Vaccine Effectiveness of R21/Matrix-M Across Malaria Transmission Settings (AVERT)

R21/MM Dosing, Presentations, and Preservatives

Targeting High Risk Populations With Enhanced Reactive Focal Mass Drug Administration in Thailand

Targeting High Risk Populations With Enhanced Reactive Case Detection in Southern Lao Peoples Democratic Republic

Assessing the Safety, Immunogenicity and Ex-vivo Efficacy of Two Candidate Malaria Transmission Blocking Vaccines, Pfs25-IMX313 and Pfs45/48 Administered Alone and in Combination, in Matrix-M Adjuvant

Pharmacokinetics, Safety, Tolerability and Efficacy of a New Artemether-lumefantrine Dispersible Tablet in Infants and Neonates <5 kg Body Weight With Acute Uncomplicated Plasmodium Falciparum Malaria

Mass Vaccine and Drug Administration, Bangladesh

Mass Screening and Treatment for Reduction of Falciparum Malaria

Additional Screening With Sensitives RDTs and Malaria

Safety and Preliminary Protective Efficacy of Genetically Attenuated GA2 Parasites.

Diagnostic and Prognostic Biomarkers for Childhood Bacterial Pneumonia

Efficacy and Safety of Pyronaridine-Artesunate Versus Artemether-Lumefantrine

Human Immunity to MSP-1 in Western Kenya

Phase II Dose-ranging Study of Pyronaridine/Artesunate in Adults Patients With Plasmodium Falciparum Malaria

Malarial Immunity in Pregnant Cameroonian Women

Targeted Active Case Detection Among High Risk Populations in Southern Lao Peoples Democratic Republic

Effect of Imatinib on Suppression of Malaria Parasites in Patients With Uncomplicated Plasmodium Falciparum Malaria

DSM265 Chemoprophylaxis of Plasmodium Falciparum Malaria

Targeted Chemo-elimination (TCE) of Malaria

SJ733 Induced Blood Stage Malaria Challenge Study